Report cover image

Life Science Software Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published May 01, 2024
Length 150 Pages
SKU # FOB18812866

Description

Life Science Software Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Life Science Software Market

The life science software market size was valued at USD 14.70 billion in 2023, and the market is now projected to grow from USD 16.11 billion in 2024 to USD 36.25 billion by 2032, exhibiting a CAGR of 10.7% during the forecast period of 2024-2032.

A vast number of industries took a drastic forceful hit during the Covid period. But the life science software market certainly did not take any damage and proliferated with its sales soaring above the skies. Defense against COVID-19 has involved the modernised technology, AI, machine learning and many such other technological developments. These factors affceted the life science software market growth.

Life sciences companies want to attract new potential clients since it's crucial for them to keep up with the ever-evolving marketing trends in the industry. This helps them expand their reach and draw in new business. These particular growth driving factors have been recorded to attribute the life science software market share.

Life science software that uses data analytics speeds up scientific innovation to commercialize theories, makes analytical decision-making and collaboration easier in a complex ecosystem, provides transparent and insightful information in a highly regulated setting, and offers many other advantages.

Comprehensive Analysis of Life Science Software Market

Market segmentation is based on deployment type: on-premises and cloud. The market is divided into six application segments: supply chain management, pharmacovigilance, research and development, preclinical and clinical trials, commercial engagement and branding, and regulatory compliance.Medical research facilities, biotechnology and pharmaceutical businesses, medical device manufacturers, and other end users (genomics and others) are among the many end users of life science software.

North America is expected to be the leading region of this particular product market and is anticipated to to grow over the forecasted period and also will continue to hold the largest market share. Due to the significant number of life sciences businesses with their headquarters in the United States, North America accounted for the greatest proportion of the market. With many aiming for their home markets, the nation is the top investment destination for the largest life sciences companies worldwide.

To grow their companies globally, market participants are employing a variety of business tactics, including partnerships, mergers, and acquisitions. IQVIA Inc., Microsoft, Veeva Systems, Salesforce, Inc., SAP SE (Germany), and IQVIA Inc. (U.S.) are a few of these market participants.

In Febrauary 2024, A new alliance was revealed by Nextrove and ArisGlobal. In order to enable pharmaceutical companies to adopt updated LifeSphere technologies, the cooperation expands the pool of excellent resources available to them. With successful attempts to launch studies in the Asia Pacific region, Oracle Life Sciences and ObvioHealth extended their collaboration globally.

Segmentation Table

Attribute Details

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 10.7% from 2024 to 2032

Unit Value (USD billion)

Segmentation By Deployment

Cloud

On-premise

By Application

Preclinical and Clinical Trials

Supply chain management

Research and Development

Commercial Engagement and Branding

Pharmacovigilance

Regulatory Compliance

By End-user

Biotechnology and Pharmaceutical Companies

Medical Research Centers

Medical Device Companies

Others (Genomics and others)

By Region

North America (By Deployment, By Application, By End-user, and By Country)

- U.S. (By End-user)

- Canada (By End-user)

- Mexico (By End-user)

Europe (By Deployment, By Application, By End-user, and By Country)

- Germany (By End-user)

- U.K. (By End-user)

- France (By End-user)

- Italy (By End-user)

- Spain (By End-user)

- Russia (By End-user)

- Benelux (By End-user)

- Nordics (By End-user)

- Rest of Europe

Asia Pacific (By Deployment, By Application, By End-user, and By Country)

- China (By End-user)

- India (By End-user)

- Japan (By End-user)

- South Korea (By End-user)

- ASEAN (By End-user)

- Oceania (By End-user)

- Rest of the Asia Pacific

Middle East & Africa (By Deployment, By Application, By End-user, and By Country)

- Turkey (By End-user)

- Israel (By End-user)

- GCC (By End-user)

- North Africa (By End-user)

- South Africa (By End-user)

- Rest of the Middle East & Africa

South America (By Deployment, By Application, By End-user, and By Country)

- Brazil (By End-user)

- Argentina (By End-user)

- Rest of South America


Please Note: It will take 2-3 business days to complete the report upon order confirmation.

Table of Contents

150 Pages
1. Introduction
1.1. Definition, By Segment
1.2. Research Methodology/Approach
1.3. Data Sources
2. Executive Summary
3. Market Dynamics
3.1. Macro and Micro Economic Indicators
3.2. Drivers, Restraints, Opportunities and Trends
3.3. Impact of Generative AI
4. Competition Landscape
4.1. Business Strategies Adopted by Key Players
4.2. Consolidated SWOT Analysis of Key Players
4.3. Global Life Science Software Key Players Market Share/Ranking, 2023
5. Global Life Science Software Market Size Estimates and Forecasts, By Segments, 2019-2032
5.1. Key Findings
5.2. By Deployment (USD)
5.2.1. Cloud
5.2.2. On-premise
5.3. By Application (USD)
5.3.1. Preclinical and Clinical Trials
5.3.2. Supply Chain Management
5.3.3. Research and Development
5.3.4. Commercial Engagement and Branding
5.3.5. Pharmacovigilance
5.3.6. Regulatory Compliance
5.4. By End-user (USD)
5.4.1. Biotechnology and Pharmaceutical Companies
5.4.2. Medical Research Centers
5.4.3. Medical Device Companies
5.4.4. Others (Genomics, etc.)
5.5. By Region (USD)
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Middle East & Africa
5.5.5. South America
6. North America Life Science Software Market Size Estimates and Forecasts, By Segments, 2019-2032
6.1. Key Findings
6.2. By Deployment (USD)
6.2.1. Cloud
6.2.2. On-premise
6.3. By Application (USD)
6.3.1. Preclinical and Clinical Trials
6.3.2. Supply Chain Management
6.3.3. Research and Development
6.3.4. Commercial Engagement and Branding
6.3.5. Pharmacovigilance
6.3.6. Regulatory Compliance
6.4. By End-user (USD)
6.4.1. Biotechnology and Pharmaceutical Companies
6.4.2. Medical Research Centers
6.4.3. Medical Device Companies
6.4.4. Others
6.5. By Country (USD)
6.5.1. United States
6.5.1.1. By End-user
6.5.2. Canada
6.5.2.1. By End-user
6.5.3. Mexico
6.5.3.1. By End-user
7. Europe Life Science Software Market Size Estimates and Forecasts, By Segments, 2019-2032
7.1. Key Findings
7.2. By Deployment (USD)
7.2.1. Cloud
7.2.2. On-premise
7.3. By Application (USD)
7.3.1. Preclinical and Clinical Trials
7.3.2. Supply Chain Management
7.3.3. Research and Development
7.3.4. Commercial Engagement and Branding
7.3.5. Pharmacovigilance
7.3.6. Regulatory Compliance
7.4. By End-user (USD)
7.4.1. Biotechnology and Pharmaceutical Companies
7.4.2. Medical Research Centers
7.4.3. Medical Device Companies
7.4.4. Others
7.5. By Country (USD)
7.5.1. United Kingdom
7.5.1.1. By End-user
7.5.2. Germany
7.5.2.1. By End-user
7.5.3. France
7.5.3.1. By End-user
7.5.4. Italy
7.5.4.1. By End-user
7.5.5. Spain
7.5.5.1. By End-user
7.5.6. Russia
7.5.6.1. By End-user
7.5.7. Benelux
7.5.7.1. By End-user
7.5.8. Nordics
7.5.8.1. By End-user
7.5.9. Rest of Europe
8. Asia Pacific Life Science Software Market Size Estimates and Forecasts, By Segments, 2019-2032
8.1. Key Findings
8.2. By Deployment (USD)
8.2.1. Cloud
8.2.2. On-premise
8.3. By Application (USD)
8.3.1. Preclinical and Clinical Trials
8.3.2. Supply Chain Management
8.3.3. Research and Development
8.3.4. Commercial Engagement and Branding
8.3.5. Pharmacovigilance
8.3.6. Regulatory Compliance
8.4. By End-user (USD)
8.4.1. Biotechnology and Pharmaceutical Companies
8.4.2. Medical Research Centers
8.4.3. Medical Device Companies
8.4.4. Others
8.5. By Country (USD)
8.5.1. China
8.5.1.1. By End-user
8.5.2. India
8.5.2.1. By End-user
8.5.3. Japan
8.5.3.1. By End-user
8.5.4. South Korea
8.5.4.1. By End-user
8.5.5. ASEAN
8.5.5.1. By End-user
8.5.6. Oceania
8.5.6.1. By End-user
8.5.7. Rest of Asia Pacific
9. Middle East & Africa Life Science Software Market Size Estimates and Forecasts, By Segments, 2019-2032
9.1. Key Findings
9.2. By Deployment (USD)
9.2.1. Cloud
9.2.2. On-premise
9.3. By Application (USD)
9.3.1. Preclinical and Clinical Trials
9.3.2. Supply Chain Management
9.3.3. Research and Development
9.3.4. Commercial Engagement and Branding
9.3.5. Pharmacovigilance
9.3.6. Regulatory Compliance
9.4. By End-user (USD)
9.4.1. Biotechnology and Pharmaceutical Companies
9.4.2. Medical Research Centers
9.4.3. Medical Device Companies
9.4.4. Others
9.5. By Country (USD)
9.5.1. Turkey
9.5.1.1. By End-user
9.5.2. Israel
9.5.2.1. By End-user
9.5.3. GCC
9.5.3.1. By End-user
9.5.4. North Africa
9.5.4.1. By End-user
9.5.5. South Africa
9.5.5.1. By End-user
9.5.6. Rest of MEA
10. South America Life Science Software Market Size Estimates and Forecasts, By Segments, 2019-2032
10.1. Key Findings
10.2. By Deployment (USD)
10.2.1. Cloud
10.2.2. On-premise
10.3. By Application (USD)
10.3.1. Preclinical and Clinical Trials
10.3.2. Supply Chain Management
10.3.3. Research and Development
10.3.4. Commercial Engagement and Branding
10.3.5. Pharmacovigilance
10.3.6. Regulatory Compliance
10.4. By End-user (USD)
10.4.1. Biotechnology and Pharmaceutical Companies
10.4.2. Medical Research Centers
10.4.3. Medical Device Companies
10.4.4. Others
10.5. By Country (USD)
10.5.1. Brazil
10.5.1.1. By End-user
10.5.2. Argentina
10.5.2.1. By End-user
10.5.3. Rest of South America
11. Company Profiles for Top 10 Players (Based on data availability in public domain and/or on paid databases)
11.1. SAP SE
11.1.1. Overview
11.1.1.1. Key Management
11.1.1.2. Headquarters
11.1.1.3. Offerings/Business Segments
11.1.2. Key Details (Key details are consolidated data and not product/service specific)
11.1.2.1. Employee Size
11.1.2.2. Past and Current Revenue
11.1.2.3. Geographical Share
11.1.2.4. Business Segment Share
11.1.2.5. Recent Developments
11.2. IQVIA Inc.
11.2.1. Overview
11.2.1.1. Key Management
11.2.1.2. Headquarters
11.2.1.3. Offerings/Business Segments
11.2.2. Key Details (Key details are consolidated data and not product/service specific)
11.2.2.1. Employee Size
11.2.2.2. Past and Current Revenue
11.2.2.3. Geographical Share
11.2.2.4. Business Segment Share
11.2.2.5. Recent Developments
11.3. Microsoft
11.3.1. Overview
11.3.1.1. Key Management
11.3.1.2. Headquarters
11.3.1.3. Offerings/Business Segments
11.3.2. Key Details (Key details are consolidated data and not product/service specific)
11.3.2.1. Employee Size
11.3.2.2. Past and Current Revenue
11.3.2.3. Geographical Share
11.3.2.4. Business Segment Share
11.3.2.5. Recent Developments
11.4. Veeva Systems
11.4.1. Overview
11.4.1.1. Key Management
11.4.1.2. Headquarters
11.4.1.3. Offerings/Business Segments
11.4.2. Key Details (Key details are consolidated data and not product/service specific)
11.4.2.1. Employee Size
11.4.2.2. Past and Current Revenue
11.4.2.3. Geographical Share
11.4.2.4. Business Segment Share
11.4.2.5. Recent Developments
11.5. Salesforce, Inc.
11.5.1. Overview
11.5.1.1. Key Management
11.5.1.2. Headquarters
11.5.1.3. Offerings/Business Segments
11.5.2. Key Details (Key details are consolidated data and not product/service specific)
11.5.2.1. Employee Size
11.5.2.2. Past and Current Revenue
11.5.2.3. Geographical Share
11.5.2.4. Business Segment Share
11.5.2.5. Recent Developments
11.6. Dassault Systèmes (Medidata)
11.6.1. Overview
11.6.1.1. Key Management
11.6.1.2. Headquarters
11.6.1.3. Offerings/Business Segments
11.6.2. Key Details (Key details are consolidated data and not product/service specific)
11.6.2.1. Employee Size
11.6.2.2. Past and Current Revenue
11.6.2.3. Geographical Share
11.6.2.4. Business Segment Share
11.6.2.5. Recent Developments
11.7. Oracle
11.7.1. Overview
11.7.1.1. Key Management
11.7.1.2. Headquarters
11.7.1.3. Offerings/Business Segments
11.7.2. Key Details (Key details are consolidated data and not product/service specific)
11.7.2.1. Employee Size
11.7.2.2. Past and Current Revenue
11.7.2.3. Geographical Share
11.7.2.4. Business Segment Share
11.7.2.5. Recent Developments
11.8. CEGEDIM GROUP
11.8.1. Overview
11.8.1.1. Key Management
11.8.1.2. Headquarters
11.8.1.3. Offerings/Business Segments
11.8.2. Key Details (Key details are consolidated data and not product/service specific)
11.8.2.1. Employee Size
11.8.2.2. Past and Current Revenue
11.8.2.3. Geographical Share
11.8.2.4. Business Segment Share
11.8.2.5. Recent Developments
11.9. Optum, Inc.
11.9.1. Overview
11.9.1.1. Key Management
11.9.1.2. Headquarters
11.9.1.3. Offerings/Business Segments
11.9.2. Key Details (Key details are consolidated data and not product/service specific)
11.9.2.1. Employee Size
11.9.2.2. Past and Current Revenue
11.9.2.3. Geographical Share
11.9.2.4. Business Segment Share
11.9.2.5. Recent Developments
11.10. IBM
11.10.1. Overview
11.10.1.1. Key Management
11.10.1.2. Headquarters
11.10.1.3. Offerings/Business Segments
11.10.2. Key Details (Key details are consolidated data and not product/service specific)
11.10.2.1. Employee Size
11.10.2.2. Past and Current Revenue
11.10.2.3. Geographical Share
11.10.2.4. Business Segment Share
11.10.2.5. Recent Developments
12. Key Takeaways

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us